FGF14 and neoplasm: Therefore, newly established inhibitors targeting the tumor suppressive properties of FGF14 would be a promising therapeutic strategy for LUAC patients and need further investigation to identify the underlying molecular mechanisms, thereby enabling the development of new therapeutic options.